Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELUW) Return on Sales (2020 - 2025)

Historic Return on Sales for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to 4.37%.

  • Celularity's Return on Sales fell 26400.0% to 4.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.49%, marking a year-over-year decrease of 27600.0%. This contributed to the annual value of 1.07% for FY2024, which is 75500.0% up from last year.
  • According to the latest figures from Q3 2025, Celularity's Return on Sales is 4.37%, which was down 26400.0% from 4.28% recorded in Q2 2025.
  • In the past 5 years, Celularity's Return on Sales ranged from a high of 12.67% in Q2 2022 and a low of 30.64% during Q1 2021
  • Over the past 5 years, Celularity's median Return on Sales value was 1.73% (recorded in 2024), while the average stood at 6.73%.
  • In the last 5 years, Celularity's Return on Sales skyrocketed by 328500bps in 2022 and then tumbled by -289900bps in 2023.
  • Celularity's Return on Sales (Quarter) stood at 0.83% in 2021, then surged by 811bps to 5.92% in 2022, then tumbled by -87bps to 0.79% in 2023, then tumbled by -2551bps to 19.32% in 2024, then soared by 77bps to 4.37% in 2025.
  • Its last three reported values are 4.37% in Q3 2025, 4.28% for Q2 2025, and 1.73% during Q1 2025.